Dr. Brunstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10201 Carnegie Ave
CA-60
Cleveland, OH 44195
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 1998 - 2002
- Federal University of Rio Grande do Sul School of MedicineClass of 1990
Certifications & Licensure
- OH State Medical License 2022 - 2026
- MN State Medical License 2002 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer Start of enrollment: 2001 Apr 01
- Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant Start of enrollment: 2005 Jun 01
- Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases Start of enrollment: 2005 Jul 28
- Join now to see all
Publications & Presentations
PubMed
- 108 citationsNegative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.Claudio G. Brunstein, John E. Wagner, Daniel J. Weisdorf, Sarah Cooley, Harriet Noreen
Blood. 2008-11-16 - 296 citationsUmbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effectClaudio G. Brunstein, Jeffrey S. Miller, David H. McKenna, Keli L. Hippen, Todd E. DeFor
Blood. 2016-02-25 - 60 citationsDoes the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and ma...Navneet S. Majhail, Claudio G. Brunstein, Sarah McAvoy, Todd E. DeFor, Ahmed Al-Hazzouri
Biology of Blood and Marrow Transplantation. 2008-09-01
Journal Articles
- Diffuse Alveolar Hemorrhage Is Most Often Fatal and Is Affected by Graft Source, Conditioning Regiment Toxicity, and Engraftment KineticsErhan H Dincer, Erica D Warlick, Margaret L MacMillan, Patrick Arndt, Daniel J Weisdorf, Nelli Bejanyan, Claudio G Brunstein, Celalettin Ustun, Aleksandr Lazaryan, Ver..., Haematologica
Abstracts/Posters
- Mgta-456, an Aryl Hydrocarbon Receptor (AHR) Antagonist Based Expansion of CD34+ Hematopoietic Stem Cells (HSC), Permits Selection of Better HLA Matched Cord Blood Uni...Claudio G. Brunstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT)Claudio G. Brunstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Myeloablative Conditioning Is Preferred for Allogeneic Transplantation of Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate but Not High Disea...Claudio G. Brunstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Validation of Minnesota Acute Gvhd Risk Score and Identification of New Factors Associated with Initial Response to Steroids: Not All Gvhd Is Created Equal2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- University of Minnesota Opens First-Ever U.S. Clinical Trial of Engineered iPSC-Derived Cell Therapy for Blood CancerOctober 23rd, 2019
- First-Ever US Clinical Trial of Engineered iPSC-Derived Cell Therapy for Blood CancerOctober 21st, 2019
- Half-Matched Transplants Widen Pool of Donors for Leukemia and LymphomaJuly 8th, 2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: